Medical Toxicology Foundation Prescription Drug Abuse Prevention Grant
Number of Grants Available: 1
Funding Duration: 1-2 years
Misuse and abuse of prescription opioids, stimulants, and sedative medications has reached epidemic proportions in the United States. Overdose is now the leading cause of unintentional injury death, with most deaths caused by prescription medications overdose.
The MTF will support outstanding research/projects and other initiatives that have the potential to reduce the misuse and abuse of prescription drugs, particularly among young people. A major goal is to support the development and/or analysis of innovative prevention, treatment, and/or harm reduction strategies. The maximum amount of this grant offering is $5,000 to support direct costs of research/projects one to two years in duration. By policy, the MTF does not cover indirect costs.
Check back in 2019 for offering information and grant submission guidelines.
2015 MTF Prescription Drug Abuse Prevention Award
PI: Rachel Wightman, MD, PGY4 Emergency Medicine Resident, New York University/Bellevue, New York, NY
Current Position (2018): Assistant Professor of Emergency Medicine, Division of Medical Toxicology, Alpert Medical School of Brown University, University Emergency Medicine Foundation
Protocol: Helping enhance targeted opioid harm reduction efforts through Erowid.
2014 MTF Prescription Drug Abuse Prevention Award
PI: Katherine Boyle, MD, Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA
Current Position (2018): Clinical Instructor, Harvard Medical School, Department of Emergency Medicine, Division of Medical Toxicology, Beth Israel Deaconess Medical Center; Faculty for the Harvard Toxicology Fellowship and MA-RI Poison Control Center
Protocol: Teaching Effective Opioid Prescribing Through a Simulation Curriculum